Search

everythinglearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tazarotene gel may be more effective for acne than adapalene gel.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

UVB exposure affects retinoid metabolism, which is important for skin cancer progression and treatment.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Baricitinib works better than methotrexate for severe alopecia areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.